Amino sulfonic acid · Fact sheet
Taurine
Also known as 2-aminoethanesulfonic acid
Taurine is not an FDA-approved anti-aging treatment. A major animal study sparked longevity interest, but later human and cross-species studies did not confirm circulating taurine as a reliable aging biomarker or deficiency as a universal human aging driver.
What is Taurine?
Taurine is an amino sulfonic acid present in many tissues and involved in bile acids, cell-volume regulation, calcium signaling, and nervous-system and muscle biology.
It is not incorporated into proteins like a standard amino acid, and blood concentration may not directly represent tissue status or treatment need.
Benefits & claims
A prominent Science study reported lower taurine with age in selected data and longer lifespan in treated mice and worms.
Subsequent human cohorts and direct physiology work found stable or increasing levels with age and no consistent link to strength or mitochondrial function.
What the evidence supports
- Animal experiments reported improved health measures and lifespan in selected species.
- Human associations do not establish benefit, and other studies directly challenge the claimed age-related deficiency pattern.
Research areas
- Animal lifespan and healthspan
- Human aging biomarkers
- Muscle and mitochondrial function
- Cardiometabolic outcomes
Dosage & frequency
No established human regimenAnimal aging findings and small human studies do not establish taurine as a human longevity medicine.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
Formulation differences
- Taurine is an amino sulfonic acid; energy-drink combinations are not taurine-alone evidence.
Interactions & precautions
- Human aging-related studies do not establish an interaction profile for every medicine or taurine-containing energy-drink combination.
What is still unresolved
- A clinically effective longevity amount and schedule remain unestablished.
Side effects & risks
- Supplement trials are not large or long enough to define every uncommon harm or interaction.
- A normal or altered blood level does not automatically identify a deficiency that should be corrected.
- Commercial combination products can add ingredients and risks unrelated to taurine itself.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Limited or unclear evidenceAnimal intervention evidence is provocative, while human evidence is observational, inconsistent, and increasingly contradictory. No human longevity trial establishes benefit.
Studies
Influential multi-species study with animal intervention and human association components.
Human and cross-species data finding stable or increasing circulating taurine with age.
Human physiology study finding no association with age, strength, performance, or mitochondrial function.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
Explore 3 sourced accounts by reported effect.
Sleep: reported experiences
Daytime calm, fragmented sleep
An author described feeling calmer and more content during the day, but waking repeatedly at night during five days of taurine use.
Reported use in this account
- Product
- Taurine supplement
- Amount
- 1–2 g, as reported
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Five days
The brief, unverified account does not establish whether taurine caused either change.
Read the original accountAn unsettling sensation while falling asleep
An author described a strange sinking sensation, anxiety and dissociation after adding taurine to their evening supplements.
Reported use in this account
- Product
- Pure taurine powder
- Amount
- 0.7 g (700 mg), as reported
- Frequency
- One nighttime exposure described
- Route
- Not specified clearly
- Duration
- One exposure; symptoms occurred while falling asleep
Other exposures described: Magnesium glycinate; Inositol; Glycine; Sometimes L-theanine; Benzodiazepine taken after the symptoms
Magnesium, inositol, glycine and sometimes L-theanine were also used. The cause of the episode was not clinically established.
Read the original accountBetter focus and a calmer bedtime
A commenter described more focus with daytime coffee and a quieter mind and better sleep at night when using taurine.
Reported use in this account
- Product
- Taurine supplement
- Amount
- 1 g at work-start; a second amount at bedtime was not separately quantified
- Frequency
- At work-start and bedtime; days per week not stated
- Route
- Oral, taken with coffee
- Duration
- Not specified clearly
Other exposures described: Coffee
Concurrent caffeine and the absence of objective sleep or attention measures limit attribution.
Read the original accountMood: reported experiences
Daytime calm, fragmented sleep
An author described feeling calmer and more content during the day, but waking repeatedly at night during five days of taurine use.
Reported use in this account
- Product
- Taurine supplement
- Amount
- 1–2 g, as reported
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Five days
The brief, unverified account does not establish whether taurine caused either change.
Read the original accountAn unsettling sensation while falling asleep
An author described a strange sinking sensation, anxiety and dissociation after adding taurine to their evening supplements.
Reported use in this account
- Product
- Pure taurine powder
- Amount
- 0.7 g (700 mg), as reported
- Frequency
- One nighttime exposure described
- Route
- Not specified clearly
- Duration
- One exposure; symptoms occurred while falling asleep
Other exposures described: Magnesium glycinate; Inositol; Glycine; Sometimes L-theanine; Benzodiazepine taken after the symptoms
Magnesium, inositol, glycine and sometimes L-theanine were also used. The cause of the episode was not clinically established.
Read the original accountBetter focus and a calmer bedtime
A commenter described more focus with daytime coffee and a quieter mind and better sleep at night when using taurine.
Reported use in this account
- Product
- Taurine supplement
- Amount
- 1 g at work-start; a second amount at bedtime was not separately quantified
- Frequency
- At work-start and bedtime; days per week not stated
- Route
- Oral, taken with coffee
- Duration
- Not specified clearly
Other exposures described: Coffee
Concurrent caffeine and the absence of objective sleep or attention measures limit attribution.
Read the original accountFocus: reported experiences
Better focus and a calmer bedtime
A commenter described more focus with daytime coffee and a quieter mind and better sleep at night when using taurine.
Reported use in this account
- Product
- Taurine supplement
- Amount
- 1 g at work-start; a second amount at bedtime was not separately quantified
- Frequency
- At work-start and bedtime; days per week not stated
- Route
- Oral, taken with coffee
- Duration
- Not specified clearly
Other exposures described: Coffee
Concurrent caffeine and the absence of objective sleep or attention measures limit attribution.
Read the original accountSensory changes: reported experiences
An unsettling sensation while falling asleep
An author described a strange sinking sensation, anxiety and dissociation after adding taurine to their evening supplements.
Reported use in this account
- Product
- Pure taurine powder
- Amount
- 0.7 g (700 mg), as reported
- Frequency
- One nighttime exposure described
- Route
- Not specified clearly
- Duration
- One exposure; symptoms occurred while falling asleep
Other exposures described: Magnesium glycinate; Inositol; Glycine; Sometimes L-theanine; Benzodiazepine taken after the symptoms
Magnesium, inositol, glycine and sometimes L-theanine were also used. The cause of the episode was not clinically established.
Read the original accountApproval status
No taurine drug is FDA approved to slow aging, extend lifespan, prevent frailty, or improve general performance. Supplement marketing does not equal FDA-reviewed effectiveness.
No FDA-approved anti-aging drug use
Taurine is a normal nutrient-related molecule with animal and observational aging research, but no FDA-approved drug use for lifespan, frailty, or general performance.
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Whether taurine improves any validated human aging outcome
- Which tissue measures, if any, reflect a clinically meaningful deficiency
- Whether animal lifespan effects translate to people
- Long-term effects in diverse populations
Summary
Human data do not support taurine deficiency as a universal aging driver. Human longevity benefits remain unproven.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- pubmedTaurine deficiency as a driver of aging
Influential multi-species study with animal intervention and human association components.
- pubmedLongitudinal challenge to taurine as an aging biomarker
Human and cross-species data finding stable or increasing circulating taurine with age.
- pubmedHuman evidence against taurine deficiency as an aging driver
Human physiology study finding no association with age, strength, performance, or mitochondrial function.
- fdaFDA: dietary supplements are not preapproved for effectiveness
FDA explanation of the regulatory distinction between approved drugs and marketed dietary supplements.